EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS

ABSTRACT Background: Sepsis is an important public health issue and is associated with high treatment costs and high mortality rates. Glutamine supplementation has proven to be beneficial to the functions of the immune system, acting beneficially in the evolution of patients in severe cataboli...

Full description

Bibliographic Details
Main Authors: Emanuele Therezinha Schueda STONOGA, Roberta Zawadzki BUENO, Thais Ayumi NAGANO, Vanessa MARTINS, Sérgio Luiz ROCHA
Format: Article
Language:English
Published: Colégio Brasileiro de Cirurgia Digestiva
Series:ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000200300&lng=en&tlng=en
_version_ 1818939232583942144
author Emanuele Therezinha Schueda STONOGA
Roberta Zawadzki BUENO
Thais Ayumi NAGANO
Vanessa MARTINS
Sérgio Luiz ROCHA
author_facet Emanuele Therezinha Schueda STONOGA
Roberta Zawadzki BUENO
Thais Ayumi NAGANO
Vanessa MARTINS
Sérgio Luiz ROCHA
author_sort Emanuele Therezinha Schueda STONOGA
collection DOAJ
description ABSTRACT Background: Sepsis is an important public health issue and is associated with high treatment costs and high mortality rates. Glutamine supplementation has proven to be beneficial to the functions of the immune system, acting beneficially in the evolution of patients in severe catabolic states. Aim: To evaluate the effect of glutamine supplementation via intraperitoneal in rats, induced sepsis, considering the following organs: intestines, liver, kidneys and lungs. Methods: Male Wistar rats subjected to sepsis by ligature and cecal puncture were divided into two groups: control C (n=6) and glutamine G (n=11), in which were administered dipeptiven 20% at a dose of 2 ml/kg/day (equivalent to 0.4g N(2)-L-alanyl-L-glutamine/kg) intraperitoneally 48 h prior to sepsis induction. After 48 h they were euthanized and intestine, liver, lung and kidney were removed for histological analysis. Results: Intestinal epithelial desquamation of the control group was more intense compared to the glutamine group (p=0.008). In the kidneys, degenerative tubular epithelial changes were less severe in the animals that received glutamine (p=0.029). Regarding to the liver, glutamine group showed lower levels of cell swelling than the control group (p=0.034). In the lung there were no results with statistical significance. Conclusion: Prior intraperitoneal supplementation with glutamine in experimental animals is able to reduce the damage to the intestinal mucosa, to the kidneys and liver’s histoarchitecture.
first_indexed 2024-12-20T06:20:29Z
format Article
id doaj.art-aeddfa5ee3d749b9a2cb588fffb255b3
institution Directory Open Access Journal
issn 0102-6720
language English
last_indexed 2024-12-20T06:20:29Z
publisher Colégio Brasileiro de Cirurgia Digestiva
record_format Article
series ABCD: Arquivos Brasileiros de Cirurgia Digestiva
spelling doaj.art-aeddfa5ee3d749b9a2cb588fffb255b32022-12-21T19:50:25ZengColégio Brasileiro de Cirurgia DigestivaABCD: Arquivos Brasileiros de Cirurgia Digestiva0102-672032210.1590/0102-672020190001e1431S0102-67202019000200300EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSISEmanuele Therezinha Schueda STONOGARoberta Zawadzki BUENOThais Ayumi NAGANOVanessa MARTINSSérgio Luiz ROCHAABSTRACT Background: Sepsis is an important public health issue and is associated with high treatment costs and high mortality rates. Glutamine supplementation has proven to be beneficial to the functions of the immune system, acting beneficially in the evolution of patients in severe catabolic states. Aim: To evaluate the effect of glutamine supplementation via intraperitoneal in rats, induced sepsis, considering the following organs: intestines, liver, kidneys and lungs. Methods: Male Wistar rats subjected to sepsis by ligature and cecal puncture were divided into two groups: control C (n=6) and glutamine G (n=11), in which were administered dipeptiven 20% at a dose of 2 ml/kg/day (equivalent to 0.4g N(2)-L-alanyl-L-glutamine/kg) intraperitoneally 48 h prior to sepsis induction. After 48 h they were euthanized and intestine, liver, lung and kidney were removed for histological analysis. Results: Intestinal epithelial desquamation of the control group was more intense compared to the glutamine group (p=0.008). In the kidneys, degenerative tubular epithelial changes were less severe in the animals that received glutamine (p=0.029). Regarding to the liver, glutamine group showed lower levels of cell swelling than the control group (p=0.034). In the lung there were no results with statistical significance. Conclusion: Prior intraperitoneal supplementation with glutamine in experimental animals is able to reduce the damage to the intestinal mucosa, to the kidneys and liver’s histoarchitecture.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000200300&lng=en&tlng=enSepsisGlutaminePeritonitisRatsIntestines
spellingShingle Emanuele Therezinha Schueda STONOGA
Roberta Zawadzki BUENO
Thais Ayumi NAGANO
Vanessa MARTINS
Sérgio Luiz ROCHA
EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
ABCD: Arquivos Brasileiros de Cirurgia Digestiva
Sepsis
Glutamine
Peritonitis
Rats
Intestines
title EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
title_full EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
title_fullStr EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
title_full_unstemmed EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
title_short EFFECTS OF INTRAPERITONEAL GLUTAMINE IN THE TREATMENT OF EXPERIMENTAL SEPSIS
title_sort effects of intraperitoneal glutamine in the treatment of experimental sepsis
topic Sepsis
Glutamine
Peritonitis
Rats
Intestines
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0102-67202019000200300&lng=en&tlng=en
work_keys_str_mv AT emanueletherezinhaschuedastonoga effectsofintraperitonealglutamineinthetreatmentofexperimentalsepsis
AT robertazawadzkibueno effectsofintraperitonealglutamineinthetreatmentofexperimentalsepsis
AT thaisayuminagano effectsofintraperitonealglutamineinthetreatmentofexperimentalsepsis
AT vanessamartins effectsofintraperitonealglutamineinthetreatmentofexperimentalsepsis
AT sergioluizrocha effectsofintraperitonealglutamineinthetreatmentofexperimentalsepsis